Wilfried E. Eberhardt
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Ten-year overall survival in resectable stage-III NSCLC - Results of the randomized ESPATUE trial - Long-term survival and competing risk analysis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 02, 2025
Will platin stay forever and ever?
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 15, 2025
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Journal: Pneumologie (Stuttgart, Germany)
Published: April 12, 2024
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Journal: Pneumologie (Stuttgart, Germany)
Published: April 12, 2024
History Can Teach Us Something: Angiogenesis Inhibition Revisited.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 15, 2024
Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE).
Journal: International journal of cancer
Published: December 20, 2023
A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: November 08, 2020
Impact of EBUS-TBNA in addition to [18F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 23, 2020
Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesothelioma.
Journal: Cancer management and research
Published: November 12, 2018
How Should We Choose the Best Therapy for Elderly Patients With Stage III Non-Small-Cell Lung Cancer?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 25, 2017
In vitro 'time-to-kill' assay to assess the cidal activity dynamics of current reference drugs against Leishmania donovani and Leishmania infantum.
Journal: The Journal of antimicrobial chemotherapy
Published: April 28, 2016
Reply to the Letter to the Editor by Hendriks et al.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 14, 2015
Last Updated: 09/26/2026